Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

(Reuters) -Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of ...

FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD) shared results from the Phase 3 PURPOSE 2 trial, showcasing the efficacy of lenacapavir, an injectable HIV-1 capsid inhibitor, in preventing ...

Gilead Sciences GILD underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their ...

Oct 3 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda Medical Supply for emergency use in ...

American biopharmaceutical company Gilead Sciences, on Thursday, October 3, announced that it will donate about 5,000 vials of its antiviral drug Remdesivir for emergency use in response to the ...

But "Nobody Wants This" still manages to feel plausible and relatable — and that's because it's loosely based on creator Erin Foster's own experience falling in love with her husband ...

(Image Credits: Pixabay) Dr. Reddy’s Laboratories Ltd. on Wednesday announced that it has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead Sciences Ireland UC ...

Six drugmakers have inked voluntary licensing (VL) agreements with Gilead Sciences to manufacture and distribute generic lenacapavir, a long-acting injectable HIV drug from the American drugmaker.

(Bloomberg) -- Gilead Sciences Inc. has donated about 5,000 doses of the Remdesivir antiviral in a bid to stem an outbreak of the Marburg disease in Rwanda, Sabin Nsanzimana, the African country’s ...

Ferozsons Laboratories Limited (PSX: FEROZ) has entered into a non-exclusive voluntary license agreement with Gilead Sciences Ireland ... with headquarters in Foster City, California If you ...

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...